<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35273564</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Mapping Motor Neuron Vulnerability in the Neuraxis of Male SOD1<sup>G93A</sup> Mice Reveals Widespread Loss of Androgen Receptor Occurring Early in Spinal Motor Neurons.</ArticleTitle><Pagination><StartPage>808479</StartPage><MedlinePgn>808479</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">808479</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2022.808479</ELocationID><Abstract><AbstractText>Sex steroid hormones have been implicated as disease modifiers in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Androgens, signalling <i>via</i> the androgen receptor (AR), predominate in males, and have widespread actions in the periphery and the central nervous system (CNS). AR translocates to the cell nucleus when activated upon binding androgens, whereby it regulates transcription of target genes <i>via</i> the classical genomic signalling pathway. We previously reported that AR protein is decreased in the lumbar spinal cord tissue of symptomatic male SOD1<sup>G93A</sup> mice. Here, we further explored the changes in AR within motor neurons (MN) of the CNS, assessing their nuclear AR content and propensity to degenerate by endstage disease in male SOD1<sup>G93A</sup> mice. We observed that almost all motor neuron populations had undergone significant loss in nuclear AR in SOD1<sup>G93A</sup> mice. Interestingly, loss of nuclear AR was evident in lumbar spinal MNs as early as the pre-symptomatic age of 60 days. Several MN populations with high AR content were identified which did not degenerate in SOD1<sup>G93A</sup> mice. These included the brainstem ambiguus and vagus nuclei, and the sexually dimorphic spinal MNs: cremaster, dorsolateral nucleus (DLN) and spinal nucleus of bulbocavernosus (SNB). In conclusion, we demonstrate that AR loss directly associates with MN vulnerability and disease progression in the SOD1<sup>G93A</sup> mouse model of ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 McLeod, Chiam, Perera, Lau, Boon and Turner.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McLeod</LastName><ForeName>Victoria M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiam</LastName><ForeName>Mathew D F</ForeName><Initials>MDF</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Nirma D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Chew L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boon</LastName><ForeName>Wah Chin</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Queen Elizabeth Medical Centre, Nedlands, WA, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">androgen receptor</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">sexual dimorphism</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35273564</ArticleId><ArticleId IdType="pmc">PMC8902593</ArticleId><ArticleId IdType="doi">10.3389/fendo.2022.808479</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: From Genes to Mechanism. Nature (2016) 539(7628):197&#x2013;206. doi:&#xa0;10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon RN. Descending Pathways in Motor Control. Annu Rev Neurosci (2008) 31:195&#x2013;218. doi:&#xa0;10.1146/annurev.neuro.31.060407.125547</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.31.060407.125547</ArticleId><ArticleId IdType="pubmed">18558853</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenggeli C, Kato AC. Differential Vulnerability of Cranial Motoneurons in Mouse Models With Motor Neuron Degeneration. Neurosci Lett (2002) 335(1):39&#x2013;43. doi:&#xa0;10.1016/S0304-3940(02)01140-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(02)01140-0</ArticleId><ArticleId IdType="pubmed">12457737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Hicks S, Berna CM, Kennard C, Talbot K, Turner MR. Oculomotor Dysfunction in Amyotrophic Lateral Sclerosis: A Comprehensive Review. Arch Neurol (2011) 68(7):857&#x2013;61. doi:&#xa0;10.1001/archneurol.2011.130</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.130</ArticleId><ArticleId IdType="pubmed">21747027</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannen T, Iwata M, Toyokura Y, Nagashima K. Preservation of a Certain Motoneurone Group of the Sacral Cord in Amyotrophic Lateral Sclerosis: Its Clinical Significance. J Neurol Neurosurg Psychiatry (1977) 40(5):464&#x2013;9. doi:&#xa0;10.1136/jnnp.40.5.464</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.40.5.464</ArticleId><ArticleId IdType="pmc">PMC492721</ArticleId><ArticleId IdType="pubmed">894318</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellino R, Boido M, Vercelli A. The Dual Nature of Onuf's Nucleus: Neuroanatomical Features and Peculiarities, in Health and Disease. Front Neuroanat (2020) 14:572013. doi:&#xa0;10.3389/fnana.2020.572013</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2020.572013</ArticleId><ArticleId IdType="pmc">PMC7500142</ArticleId><ArticleId IdType="pubmed">33013330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T. Time Course of Preferential Motor Unit Loss in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Neurobiol Dis (2007) 28(2):154&#x2013;64. doi:&#xa0;10.1016/j.nbd.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M, Sharma A, Lyashchenko AK, Shneider NA. Gamma Motor Neurons Survive and Exacerbate Alpha Motor Neuron Degeneration in ALS. Proc Natl Acad Sci U S A (2016) 113(51):E8316&#x2013;25. doi:&#xa0;10.1073/pnas.1605210113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The Phenotypic Variability of Amyotrophic Lateral Sclerosis. Nat Rev Neurol (2014) 10(11):661&#x2013;70. doi:&#xa0;10.1038/nrneurol.2014.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS Motor Phenotype Heterogeneity, Focality, and Spread: Deconstructing Motor Neuron Degeneration. Neurology (2009) 73(10):805&#x2013;11. doi:&#xa0;10.1212/WNL.0b013e3181b6bbbd</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of Gender in Amyotrophic Lateral Sclerosis. Gend Med (2010) 7(6):557&#x2013;70. doi:&#xa0;10.1016/j.genm.2010.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Jr., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med (2017) 377(16):1602. doi:&#xa0;10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic Heterogeneity of Amyotrophic Lateral Sclerosis: A Population Based Study. J Neurol Neurosurg Psychiatry (2011) 82(7):740&#x2013;6. doi:&#xa0;10.1136/jnnp.2010.235952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemppainen JA, Lane MV, Sar M, Wilson EM. Androgen Receptor Phosphorylation, Turnover, Nuclear Transport, and Transcriptional Activation. Specificity for Steroids and Antihormones. J Biol Chem (1992) 267(2):968&#x2013;74. doi: 10.1016/S0021-9258(18)48380-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)48380-9</ArticleId><ArticleId IdType="pubmed">1730684</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadal M, Prekovic S, Gallastegui N, Helsen C, Abella M, Zielinska K, et al. . Structure of the Homodimeric Androgen Receptor Ligand-Binding Domain. Nat Commun (2017) 8:14388. doi:&#xa0;10.1038/ncomms14388</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14388</ArticleId><ArticleId IdType="pmc">PMC5303882</ArticleId><ArticleId IdType="pubmed">28165461</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner LP. Possible Role of Androgen Receptors in Amyotrophic Lateral Sclerosis. A Hypothesis. Arch Neurol (1980) 37(3):129&#x2013;31. doi:&#xa0;10.1001/archneur.1980.00500520027002</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1980.00500520027002</ArticleId><ArticleId IdType="pubmed">7356416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sar M, Stumpf WE. Androgen Concentration in Motor Neurons of Cranial Nerves and Spinal Cord. Science (1977) 197(4298):77&#x2013;9. doi:&#xa0;10.1126/science.867053</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.867053</ArticleId><ArticleId IdType="pubmed">867053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A, Matsuura T, Tashiro K, Moriwaka F, Demura T, Koyanagi T, et al. . Expression of Androgen Receptor in X-Linked Spinal and Bulbar Muscular Atrophy and Amyotrophic Lateral Sclerosis. J Neurol Neurosurg Psychiatry (1994) 57(10):1274&#x2013;5. doi:&#xa0;10.1136/jnnp.57.10.1274</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.57.10.1274</ArticleId><ArticleId IdType="pmc">PMC485506</ArticleId><ArticleId IdType="pubmed">7931399</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen Receptor Gene Mutations in X-Linked Spinal and Bulbar Muscular Atrophy. Nature (1991) 352(6330):77&#x2013;9. doi:&#xa0;10.1038/352077a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas PS, Jr, Fraley GS, Damian V, Woodke LB, Zapata F, Sopher BL, et al. . Loss of Endogenous Androgen Receptor Protein Accelerates Motor Neuron Degeneration and Accentuates Androgen Insensitivity in a Mouse Model of X-Linked Spinal and Bulbar Muscular Atrophy. Hum Mol Genet (2006) 15(14):2225&#x2013;38. doi:&#xa0;10.1093/hmg/ddl148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddl148</ArticleId><ArticleId IdType="pubmed">16772330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH. Altered Transcriptional Regulation in Cells Expressing the Expanded Polyglutamine Androgen Receptor. Hum Mol Genet (2002) 11(17):1967&#x2013;76. doi:&#xa0;10.1093/hmg/11.17.1967</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.17.1967</ArticleId><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for Reporting Experiments Involving Animals: The ARRIVE Guidelines. Br J Pharmacol (2010) 160(7):1573&#x2013;6. doi:&#xa0;10.1111/j.1476-5381.2010.00873.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2010.00873.x</ArticleId><ArticleId IdType="pmc">PMC2936829</ArticleId><ArticleId IdType="pubmed">20649560</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. . Motor Neuron Degeneration in Mice That Express a Human Cu,Zn Superoxide Dismutase Mutation. Science (1994) 264(5166):1772&#x2013;5. doi:&#xa0;10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD. Neuronal Subtype-Specific Genes That Control Corticospinal Motor Neuron Development In Vivo. Neuron (2005) 45(2):207&#x2013;21. doi:&#xa0;10.1016/j.neuron.2004.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.12.036</ArticleId><ArticleId IdType="pubmed">15664173</ArticleId></ArticleIdList></Reference><Reference><Citation>Huff T, Daly DT. Neuroanatomy, Cranial Nerve 5 (Trigeminal), in StatPearls. Treasure Island (FL): StatPearls Publishing LLC; (2021). StatPearls PublishingCopyright &#xa9; 2021.</Citation></Reference><Reference><Citation>Friese A, Kaltschmidt JA, Ladle DR, Sigrist M, Jessell TM, Arber S. Gamma and Alpha Motor Neurons Distinguished by Expression of Transcription Factor Err3. Proc Natl Acad Sci U S A (2009) 106(32):13588&#x2013;93. doi:&#xa0;10.1073/pnas.0906809106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906809106</ArticleId><ArticleId IdType="pmc">PMC2716387</ArticleId><ArticleId IdType="pubmed">19651609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulak D, Naqvi IA. Neuroanatomy, Cranial Nerve 7 (Facial). In: StatPearls. Treasure Island (FL: StatPearls Publishing LLC; (2021). StatPearls Publishing Copyright &#xa9; 2021.</Citation></Reference><Reference><Citation>Morita-Isogai Y, Sato H, Saito M, Kuramoto E, Yin DX, Kaneko T, et al. . A Distinct Functional Distribution of Alpha and Gamma Motoneurons in the Rat Trigeminal Motor Nucleus. Brain Struct Funct (2017) 222(7):3231&#x2013;9. doi:&#xa0;10.1007/s00429-017-1400-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-017-1400-8</ArticleId><ArticleId IdType="pubmed">28326439</ArticleId></ArticleIdList></Reference><Reference><Citation>Han AY, Gupta S, Novitch BG. Molecular Specification of Facial Branchial Motor Neurons in Vertebrates. Dev Biol (2018) 436(1):5&#x2013;13. doi:&#xa0;10.1016/j.ydbio.2018.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2018.01.019</ArticleId><ArticleId IdType="pubmed">29391164</ArticleId></ArticleIdList></Reference><Reference><Citation>Petko B, Tadi P. Neuroanatomy, Nucleus Ambiguus. In: StatPearls. Treasure Island (FL: StatPearls Publishing LLC; (2021). StatPearls Publishing Copyright &#xa9; 2021.</Citation></Reference><Reference><Citation>Bacskai T, Rusznak Z, Paxinos G, Watson C. Musculotopic Organization of the Motor Neurons Supplying the Mouse Hindlimb Muscles: A Quantitative Study Using Fluoro-Gold Retrograde Tracing. Brain Struct Funct (2014) 219(1):303&#x2013;21. doi:&#xa0;10.1007/s00429-012-0501-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-012-0501-7</ArticleId><ArticleId IdType="pubmed">23288256</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan CL, Breedlove SM, Arnold AP. Sexual Dimorphism and the Influence of Neonatal Androgen in the Dorsolateral Motor Nucleus of the Rat Lumbar Spinal Cord. Brain Res (1982) 249(2):309&#x2013;14. doi:&#xa0;10.1016/0006-8993(82)90065-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(82)90065-8</ArticleId><ArticleId IdType="pubmed">7139305</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor Neuron Vulnerability and Resistance in Amyotrophic Lateral Sclerosis. Acta Neuropathol (2017) 133(6):863&#x2013;85. doi:&#xa0;10.1007/s00401-017-1708-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD. Motor Neuron Susceptibility in ALS/FTD. Front Neurosci (2019) 13:532. doi:&#xa0;10.3389/fnins.2019.00532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L, Allodi I, Nichterwitz S, Nizzardo M, Simone C, Corti S, et al. . Motor Neurons With Differential Vulnerability to Degeneration Show Distinct Protein Signatures in Health and ALS. Neuroscience (2015) 291:216&#x2013;29. doi:&#xa0;10.1016/j.neuroscience.2015.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.013</ArticleId><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod VM, Chiam MDF, Lau CL, Rupasinghe TW, Boon WC, Turner BJ. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates With Disease Progression in ALS Mice. Endocrinology (2020) 161(9):bqaa113. doi:&#xa0;10.1210/endocr/bqaa113</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa113</ArticleId><ArticleId IdType="pubmed">32621747</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Jara JH, Lagrimas AK, Pytel P, Roos RP, Mesulam MM, et al. . Apical Dendrite Degeneration, a Novel Cellular Pathology for Betz Cells in ALS. Sci Rep (2017) 7:41765. doi:&#xa0;10.1038/srep41765</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41765</ArticleId><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Gozutok O, Ozdinler PH. Complexity of Generating Mouse Models to Study the Upper Motor Neurons: Let Us Shift Focus From Mice to Neurons. Int J Mol Sci (2019) 20(16):3848. doi:&#xa0;10.3390/ijms20163848</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20163848</ArticleId><ArticleId IdType="pmc">PMC6720674</ArticleId><ArticleId IdType="pubmed">31394733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH, Jr, Macklis JD. Corticospinal Motor Neurons and Related Subcerebral Projection Neurons Undergo Early and Specific Neurodegeneration in Hsod1g(9)(3)A Transgenic ALS Mice. J Neurosci (2011) 31(11):4166&#x2013;77. doi:&#xa0;10.1523/JNEUROSCI.4184-10.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4184-10.2011</ArticleId><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasvoina MV, Genc B, Jara JH, Sheets PL, Quinlan KA, Milosevic A, et al. . eGFP Expression Under UCHL1 Promoter Genetically Labels Corticospinal Motor Neurons and a Subpopulation of Degeneration-Resistant Spinal Motor Neurons in an ALS Mouse Model. J Neurosci (2013) 33(18):7890&#x2013;904. doi:&#xa0;10.1523/JNEUROSCI.2787-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2787-12.2013</ArticleId><ArticleId IdType="pmc">PMC3963467</ArticleId><ArticleId IdType="pubmed">23637180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S. Pathways and Genes Differentially Expressed in the Motor Cortex of Patients With Sporadic Amyotrophic Lateral Sclerosis. BMC Genomics (2007) 8:26. doi:&#xa0;10.1186/1471-2164-8-26</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-8-26</ArticleId><ArticleId IdType="pmc">PMC1796866</ArticleId><ArticleId IdType="pubmed">17244347</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrachina M, Castano E, Dalfo E, Maes T, Buesa C, Ferrer I. Reduced Ubiquitin C-Terminal Hydrolase-1 Expression Levels in Dementia With Lewy Bodies. Neurobiol Dis (2006) 22(2):265&#x2013;73. doi:&#xa0;10.1016/j.nbd.2005.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.11.005</ArticleId><ArticleId IdType="pubmed">16380264</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, et al. . Oxidative Modifications and Down-Regulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 Associated With Idiopathic Parkinson's and Alzheimer's Diseases. J Biol Chem (2004) 279(13):13256&#x2013;64. doi:&#xa0;10.1074/jbc.M314124200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M314124200</ArticleId><ArticleId IdType="pubmed">14722078</ArticleId></ArticleIdList></Reference><Reference><Citation>Oswald MJ, Tantirigama ML, Sonntag I, Hughes SM, Empson RM. Diversity of Layer 5 Projection Neurons in the Mouse Motor Cortex. Front Cell Neurosci (2013) 7:174. doi:&#xa0;10.3389/fncel.2013.00174</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00174</ArticleId><ArticleId IdType="pmc">PMC3797544</ArticleId><ArticleId IdType="pubmed">24137110</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Masugi-Tokita M, Takanami K, Yamada S, Kawata M. Testosterone has Sublayer-Specific Effects on Dendritic Spine Maturation Mediated by BDNF and PSD-95 in Pyramidal Neurons in the Hippocampus CA1 Area. Brain Res (2012) 1484:76&#x2013;84. doi:&#xa0;10.1016/j.brainres.2012.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.09.028</ArticleId><ArticleId IdType="pubmed">23010313</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Chew C, Munoz F, Sengelaub DR. Neuroprotective Effects of Testosterone Metabolites and Dependency on Receptor Action on the Morphology of Somatic Motoneurons Following the Death of Neighboring Motoneurons. Dev Neurobiol (2017) 77(6):691&#x2013;707. doi:&#xa0;10.1002/dneu.22445</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22445</ArticleId><ArticleId IdType="pmc">PMC5332478</ArticleId><ArticleId IdType="pubmed">27569375</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER. Androgen Cell Signaling Pathways Involved in Neuroprotective Actions. Horm Behav (2008) 53(5):693&#x2013;705. doi:&#xa0;10.1016/j.yhbeh.2007.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yhbeh.2007.11.006</ArticleId><ArticleId IdType="pmc">PMC2424283</ArticleId><ArticleId IdType="pubmed">18222446</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Moglia C, Canosa A, Manera U, D'Ovidio F, Vasta R, et al. . ALS Phenotype is Influenced by Age, Sex, and Genetics: A Population-Based Study. Neurology (2020) 94(8):e802&#x2013;10. doi:&#xa0;10.1212/WNL.0000000000008869</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, et al. . Pathogenesis and Therapy of Spinal and Bulbar Muscular Atrophy (SBMA). Prog Neurobiol (2012) 99(3):246&#x2013;56. doi:&#xa0;10.1016/j.pneurobio.2012.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2012.05.007</ArticleId><ArticleId IdType="pubmed">22609045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritzer M. The Distribution of Immunoreactivity for Intracellular Androgen Receptors in the Cerebral Cortex of Hormonally Intact Adult Male and Female Rats: Localization in Pyramidal Neurons Making Corticocortical Connections. Cereb Cortex (2004) 14(3):268&#x2013;80. doi:&#xa0;10.1093/cercor/bhg127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhg127</ArticleId><ArticleId IdType="pubmed">14754867</ArticleId></ArticleIdList></Reference><Reference><Citation>Clasca F, Rubio-Garrido P, Jabaudon D. Unveiling the Diversity of Thalamocortical Neuron Subtypes. Eur J Neurosci (2012) 35(10):1524&#x2013;32. doi:&#xa0;10.1111/j.1460-9568.2012.08033.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2012.08033.x</ArticleId><ArticleId IdType="pubmed">22606998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal Dementia. Lancet (2015) 386(10004):1672&#x2013;82. doi:&#xa0;10.1016/S0140-6736(15)00461-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00461-4</ArticleId><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A, Mento G, Calvo V, Querin G, D'Ascenzo C, Volpato C, et al. . Female Gender Doubles Executive Dysfunction Risk in ALS: A Case-Control Study in 165 Patients. J Neurol Neurosurg Psychiatry (2015) 86(5):574&#x2013;9. doi:&#xa0;10.1136/jnnp-2014-307654</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-307654</ArticleId><ArticleId IdType="pubmed">25063584</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobiansky DJ, Wallin-Miller KG, Floresco SB, Wood RI, Soma KK. Androgen Regulation of the Mesocorticolimbic System and Executive Function. Front Endocrinol (Lausanne) (2018) 9:279. doi:&#xa0;10.3389/fendo.2018.00279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00279</ArticleId><ArticleId IdType="pmc">PMC5996102</ArticleId><ArticleId IdType="pubmed">29922228</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh DJ, Root JC, Nelson CJ, Morris MJ. Androgen-Deprivation Therapy, Dementia, and Cognitive Dysfunction in Men With Prostate Cancer: How Much Smoke and How Much Fire? Cancer (2018) 124(7):1326&#x2013;34. doi:&#xa0;10.1002/cncr.31153</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.31153</ArticleId><ArticleId IdType="pmc">PMC5885282</ArticleId><ArticleId IdType="pubmed">29338083</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimchinsky EA, Young WG, Yeung G, Shah RA, Gordon JW, Bloom FE, et al. . Differential Vulnerability of Oculomotor, Facial, and Hypoglossal Nuclei in G86R Superoxide Dismutase Transgenic Mice. J Comp Neurol (2000) 416(1):112&#x2013;25. doi:&#xa0;10.1002/(SICI)1096-9861(20000103)416:1&lt;112::AID-CNE9&gt;3.0.CO;2-K</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(20000103)416:1&lt;112::AID-CNE9&gt;3.0.CO;2-K</ArticleId><ArticleId IdType="pubmed">10578106</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppenbauer CB, Tanzer L, DonCarlos LL, Jones KJ. Gonadal Steroid Attenuation of Developing Hamster Facial Motoneuron Loss by Axotomy: Equal Efficacy of Testosterone, Dihydrotestosterone, and 17-Beta Estradiol. J&#xa0;Neurosci (2005) 25(16):4004&#x2013;13. doi:&#xa0;10.1523/JNEUROSCI.5279-04.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5279-04.2005</ArticleId><ArticleId IdType="pmc">PMC6724945</ArticleId><ArticleId IdType="pubmed">15843602</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetzlaff JE, Huppenbauer CB, Tanzer L, Alexander TD, Jones KJ. Motoneuron Injury and Repair: New Perspectives on Gonadal Steroids as Neurotherapeutics. J Mol Neurosci (2006) 28(1):53&#x2013;64. doi:&#xa0;10.1385/JMN:28:1:53</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMN:28:1:53</ArticleId><ArticleId IdType="pubmed">16632875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu WH, Yu MC. Acceleration of the Regeneration of the Crushed Hypoglossal Nerve by Testosterone. Exp Neurol (1983) 80(2):349&#x2013;60. doi:&#xa0;10.1016/0014-4886(83)90288-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4886(83)90288-1</ArticleId><ArticleId IdType="pubmed">6840243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu WH, Cao CG. Muscle as the Primary Site for Testosterone to Promote Survival of Axotomized Motoneurons. Neuroreport (1991) 2(5):258&#x2013;60. doi:&#xa0;10.1097/00001756-199105000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199105000-00011</ArticleId><ArticleId IdType="pubmed">1912458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawa KA, Jacob JM, Jones KJ. Testosterone Regulation of the Regenerative Properties of Injured Rat Sciatic Motor Neurons. J Neurosci Res (1993) 35(3):268&#x2013;73. doi:&#xa0;10.1002/jnr.490350306</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490350306</ArticleId><ArticleId IdType="pubmed">8350388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fargo KN, Galbiati M, Foecking EM, Poletti A, Jones KJ. Androgen Regulation of Axon Growth and Neurite Extension in Motoneurons. Horm Behav (2008) 53(5):716&#x2013;28. doi:&#xa0;10.1016/j.yhbeh.2008.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yhbeh.2008.01.014</ArticleId><ArticleId IdType="pmc">PMC2408920</ArticleId><ArticleId IdType="pubmed">18387610</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J. ALS as a Distal Axonopathy: Molecular Mechanisms Affecting Neuromuscular Junction Stability in the Presymptomatic Stages of the Disease. Front Neurosci (2014) 8:252. doi:&#xa0;10.3389/fnins.2014.00252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, O'Bryant EL, Jordan CL. Androgen Receptor Immunoreactivity in Skeletal Muscle: Enrichment at the Neuromuscular Junction. J Comp Neurol (2004) 473(1):59&#x2013;72. doi:&#xa0;10.1002/cne.20088</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20088</ArticleId><ArticleId IdType="pubmed">15067718</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols NL, Gowing G, Satriotomo I, Nashold LJ, Dale EA, Suzuki M, et al. . Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis. Am J Respir Crit Care Med (2013) 187(5):535&#x2013;42. doi:&#xa0;10.1164/rccm.201206-1072OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201206-1072OC</ArticleId><ArticleId IdType="pmc">PMC3733409</ArticleId><ArticleId IdType="pubmed">23220913</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco CE, Zhan WZ, Fang YH, Sieck GC. Exogenous Testosterone Treatment Decreases Diaphragm Neuromuscular Transmission Failure in Male Rats. J Appl Physiol (1985) (2001) 90(3):850&#x2013;6. doi:&#xa0;10.1152/jappl.2001.90.3.850</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.2001.90.3.850</ArticleId><ArticleId IdType="pubmed">11181592</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Mu EW, Noakes PG, Lavidis NA, Bellingham MC. Marked Changes in Dendritic Structure and Spine Density Precede Significant Neuronal Death in Vulnerable Cortical Pyramidal Neuron Populations in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Acta Neuropathol Commun (2016) 4(1):77. doi:&#xa0;10.1186/s40478-016-0347-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0347-y</ArticleId><ArticleId IdType="pmc">PMC4973034</ArticleId><ArticleId IdType="pubmed">27488828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Mu EWH, Lavidis NA, Noakes PG, Bellingham MC. Motor Areas Show Altered Dendritic Structure in an Amyotrophic Lateral Sclerosis Mouse Model. Front Neurosci (2017) 11:609. doi:&#xa0;10.3389/fnins.2017.00609</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00609</ArticleId><ArticleId IdType="pmc">PMC5672020</ArticleId><ArticleId IdType="pubmed">29163013</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Mu EWH, Lavidis NA, Noakes PG, Bellingham MC. Size-Dependent Dendritic Maladaptations of Hypoglossal Motor Neurons in SOD1(G93A) Mice. Anat Rec (Hoboken) (2020) 304(7):1562&#x2013;81. doi:&#xa0;10.1002/ar.24542</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.24542</ArticleId><ArticleId IdType="pubmed">33099869</ArticleId></ArticleIdList></Reference><Reference><Citation>Fargo KN, Sengelaub DR. Androgenic, But Not Estrogenic, Protection of Motoneurons From Somal and Dendritic Atrophy Induced by the Death of Neighboring Motoneurons. Dev Neurobiol (2007) 67(8):1094&#x2013;106. doi:&#xa0;10.1002/dneu.20454</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20454</ArticleId><ArticleId IdType="pmc">PMC2747260</ArticleId><ArticleId IdType="pubmed">17565709</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli MP, Casti A, Casu A, Frau R, Bortolato M, Spiga S, et al. . Regional Distribution of 5alpha-Reductase Type 2 in the Adult Rat Brain: An Immunohistochemical Analysis. Psychoneuroendocrinology (2013) 38(2):281&#x2013;93. doi:&#xa0;10.1016/j.psyneuen.2012.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2012.06.008</ArticleId><ArticleId IdType="pmc">PMC3762250</ArticleId><ArticleId IdType="pubmed">22776423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi P, Bendotti C, Simeoni S, Piccioni F, Guerini V, Marron TU, et al. . Androgen 5-Alpha-Reductase Type 2 is Highly Expressed and Active in Rat Spinal Cord Motor Neurones. J Neuroendocrinol (2003) 15(9):882&#x2013;7. doi:&#xa0;10.1046/j.1365-2826.2003.01074.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2826.2003.01074.x</ArticleId><ArticleId IdType="pubmed">12899683</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawal N, Kaur J, Kaur K, Gombar S. Dihydrotestosterone in Amyotrophic Lateral Sclerosis-The Missing Link? Brain Behav (2020) 10(11):e01645. doi:&#xa0;10.1002/brb3.1645</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1645</ArticleId><ArticleId IdType="pmc">PMC7667368</ArticleId><ArticleId IdType="pubmed">33047895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YE, Ko CP. Dihydrotestosterone Ameliorates Degeneration in Muscle, Axons and Motoneurons and Improves Motor Function in Amyotrophic Lateral Sclerosis Model Mice. PLoS One (2012) 7(5):e37258. doi:&#xa0;10.1371/journal.pone.0037258</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037258</ArticleId><ArticleId IdType="pmc">PMC3351454</ArticleId><ArticleId IdType="pubmed">22606355</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>